ASAM Review Course

Presentations from the October 26-28 Review Course in Addiction Medicine can be found below;  Epidemiology  Rosa M. Crum, M.D., M.H.S.   Neurobiology 1  Neurobiology 2   Eliot L. Gardner, Ph.D.  Physician Impairment:  The Scientific and Professional Challenge  Louis E. Baxter, Sr., M.D., FASAM   Psychiatric Comorbidities  Richard K. Ries, M.D., FASAM  Medical Comorbidities   Adam Gordon, M.D., M.P.H., FACP, FASAM  Maternal/Child Issues in Addiction:  Pregnancy and More  Marjorie Meyer, M.D., FACOG  Clinical Challenges in Prescribing for Controlled Drugs  and Special Issues in the Treatment of Chronic Pain  Theodore V. Parran, Jr., M.D., FACP  Alcohol  2- Alcohol Treatmentl    Mark Willenbring, M.D.  Sedative-Hypnotics  Theodore V. Parran, Jr., M.D., FACP  Understanding Addiction: Translating Science to Practice:    Edwin A. Salsitz, M.D., FASAM  Non-Pharmacologic Therapies, Nicole Kosanke, Ph.D.  Opioids   Edwin A. Salsitz, M.D., FASAM  1 - Opioid Agonist Therapy – Buprenorphine & Methadone, Edwin A. Salsitz, M.D.  2 - Opioid Agonist Therapy – Buprenorphine & Methadone , Edwin A. Salsitz, M.D.   Twelve Step Programs   Lee Ann Kaskutas, Ph.D.  Mechanics of the ASAM Certification Examination, Christopher Weirs, MPA  Exam Questions - Michael Weaver, M.D., FASAM  Exam Preparation - John Standrisdge, M.D., FASAM   Stimulants   Karen Drexler, M.D.  Clinical Uses of Drug Testing    Robert L. DuPont, M.D.   Marijuana  Carl L. Hart, Ph.D.  Dissociatives, Hallucinogens, Steroids, and Inhalants  Shannon C. Miller, M.D., FASAM, FAPA, CMRO  Tobacco, Terry A. Rustin, M.D., FASAM